ΒΑΣΙΛΟΠΟΥΛΟΣ ΧΑΡΗΣ (2009)


Papers

 A1C Variability and the Risk of Micronascular Complications in Type 1 Diabetes
 Autoantibodies in type 1 diabetes
 C-Peptide Effects on Renal Physiology and Diabetes
 Current status of islet cell transplantation
 Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes randomised, placebo-controlled trials
 Embryonic stem cells to beta-cells by understanding pancreas development
 Fasting plasma C- Peptide and micro-and macrovavascular Complications in a large Clinic-based Cohort of type 1 diabetic people
 Fasting plasma C- Peptide and micro-and macrovavascular Complications in a large Clinic-based Cohort of type 1 diabetic people
 Fully Automated Closed-Loop Insulin Delivery Versus semi automated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
 GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
 Immunology and Genetics of Type 1 Diabetes
 Impact of Diabetes and its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Controle and Compications Trial
 Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
 Kidney and Pancreas Transplantation in Type 1 Diabetes Mellitus
 Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years
 Meta-analysis of Quality of Life Outcomes Following Diabetes Self-management Training
 Preparation and evaluation on mucinated sodium alginate microparticles for oral delivery of insulin
 Rate of b-Cell Destruction in Type 1 Diabetes Influences the Development of Diabetic Retinopathy Protective Effect of Residual b-Cell Function for More Than 10 Ye
 Revascularization of Transplanted Islets
 Role of C-Peptide in the Regulation of Microvascular Blood Flow
 Shared and Distinct Genetic Variants in Type 1 DIabetes and Celiac Disease
 TDiabetes 1 and 2, or one and the same Progress with the accelerator hypothesis
 YKL-40 in Type 1 Diabetes